Cargando…

Impacts of government supervision on hospitalization costs for inpatients with COPD: An interrupted time series study

To address the remaining medical misconducts after the zero-makeup drug policy (ZMDP), e.g., over-examinations, China has given the priority to government supervision on medical institutions. This study evaluated the effect of government supervision on medical costs among inpatients with chronic obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Peiyi, Duan, Zhanqi, Zhang, Ziwu, He, Yunzhen, Li, Weimin, Jin Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004713/
https://www.ncbi.nlm.nih.gov/pubmed/32000429
http://dx.doi.org/10.1097/MD.0000000000018977
_version_ 1783494785628110848
author Li, Peiyi
Duan, Zhanqi
Zhang, Ziwu
He, Yunzhen
Li, Weimin
Jin Wen,
author_facet Li, Peiyi
Duan, Zhanqi
Zhang, Ziwu
He, Yunzhen
Li, Weimin
Jin Wen,
author_sort Li, Peiyi
collection PubMed
description To address the remaining medical misconducts after the zero-makeup drug policy (ZMDP), e.g., over-examinations, China has given the priority to government supervision on medical institutions. This study evaluated the effect of government supervision on medical costs among inpatients with chronic obstructive pulmonary disease (COPD) in Sichuan province, the first province in China where the medical supervision was conducted. A linear interrupted time series (ITS) model was employed to analyze data about 72,113 inpatients from 32 hospitals. Monthly average medicine costs, diagnostic costs, and medical services costs, nursing costs from January 2015 to June 2018 were analyzed, respectively. The average hospitalization costs fell with a monthly trend of 42.90Yuan before the implementation of supervision (P < .001), and the declining trend remained with the more dramatic rate (−158.70Yuan, P < .001) after the government audit carried out. For western medicine costs, the monthly decreasing trend remained after the implementation of supervision (−66.44Yuan, P < .001); meanwhile, the monthly upward trend was changed into a downtrend trend for traditional Chinese medicine costs (−11.80Yuan, P = .009). Additionally, the increasing monthly trend in average diagnostics costs disappeared after government supervision, and was inversed to an insignificant decreasing trend at the rate of 26.18Yuan per month. Moreover, the previous upward trends were changed into downward trends for both medical service costs and nursing costs (P = .056, −44.71Yuan; P = .007, −11.17Yuan, respectively) after the supervision carried out. Our findings reveal that government supervision in Sichuan province was applicable to curb the growth of medical costs for inpatients with COPD, which may reflect its role in restraining physicians’ compensating behaviors after the ZMDP. The government medical supervision holds promise to dismiss medical misconducts in Sichuan province, the experience of which may offer implications for other regions of China as well as other low- and middle-income countries.
format Online
Article
Text
id pubmed-7004713
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-70047132020-02-18 Impacts of government supervision on hospitalization costs for inpatients with COPD: An interrupted time series study Li, Peiyi Duan, Zhanqi Zhang, Ziwu He, Yunzhen Li, Weimin Jin Wen, Medicine (Baltimore) 6600 To address the remaining medical misconducts after the zero-makeup drug policy (ZMDP), e.g., over-examinations, China has given the priority to government supervision on medical institutions. This study evaluated the effect of government supervision on medical costs among inpatients with chronic obstructive pulmonary disease (COPD) in Sichuan province, the first province in China where the medical supervision was conducted. A linear interrupted time series (ITS) model was employed to analyze data about 72,113 inpatients from 32 hospitals. Monthly average medicine costs, diagnostic costs, and medical services costs, nursing costs from January 2015 to June 2018 were analyzed, respectively. The average hospitalization costs fell with a monthly trend of 42.90Yuan before the implementation of supervision (P < .001), and the declining trend remained with the more dramatic rate (−158.70Yuan, P < .001) after the government audit carried out. For western medicine costs, the monthly decreasing trend remained after the implementation of supervision (−66.44Yuan, P < .001); meanwhile, the monthly upward trend was changed into a downtrend trend for traditional Chinese medicine costs (−11.80Yuan, P = .009). Additionally, the increasing monthly trend in average diagnostics costs disappeared after government supervision, and was inversed to an insignificant decreasing trend at the rate of 26.18Yuan per month. Moreover, the previous upward trends were changed into downward trends for both medical service costs and nursing costs (P = .056, −44.71Yuan; P = .007, −11.17Yuan, respectively) after the supervision carried out. Our findings reveal that government supervision in Sichuan province was applicable to curb the growth of medical costs for inpatients with COPD, which may reflect its role in restraining physicians’ compensating behaviors after the ZMDP. The government medical supervision holds promise to dismiss medical misconducts in Sichuan province, the experience of which may offer implications for other regions of China as well as other low- and middle-income countries. Wolters Kluwer Health 2020-01-31 /pmc/articles/PMC7004713/ /pubmed/32000429 http://dx.doi.org/10.1097/MD.0000000000018977 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 6600
Li, Peiyi
Duan, Zhanqi
Zhang, Ziwu
He, Yunzhen
Li, Weimin
Jin Wen,
Impacts of government supervision on hospitalization costs for inpatients with COPD: An interrupted time series study
title Impacts of government supervision on hospitalization costs for inpatients with COPD: An interrupted time series study
title_full Impacts of government supervision on hospitalization costs for inpatients with COPD: An interrupted time series study
title_fullStr Impacts of government supervision on hospitalization costs for inpatients with COPD: An interrupted time series study
title_full_unstemmed Impacts of government supervision on hospitalization costs for inpatients with COPD: An interrupted time series study
title_short Impacts of government supervision on hospitalization costs for inpatients with COPD: An interrupted time series study
title_sort impacts of government supervision on hospitalization costs for inpatients with copd: an interrupted time series study
topic 6600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004713/
https://www.ncbi.nlm.nih.gov/pubmed/32000429
http://dx.doi.org/10.1097/MD.0000000000018977
work_keys_str_mv AT lipeiyi impactsofgovernmentsupervisiononhospitalizationcostsforinpatientswithcopdaninterruptedtimeseriesstudy
AT duanzhanqi impactsofgovernmentsupervisiononhospitalizationcostsforinpatientswithcopdaninterruptedtimeseriesstudy
AT zhangziwu impactsofgovernmentsupervisiononhospitalizationcostsforinpatientswithcopdaninterruptedtimeseriesstudy
AT heyunzhen impactsofgovernmentsupervisiononhospitalizationcostsforinpatientswithcopdaninterruptedtimeseriesstudy
AT liweimin impactsofgovernmentsupervisiononhospitalizationcostsforinpatientswithcopdaninterruptedtimeseriesstudy
AT jinwen impactsofgovernmentsupervisiononhospitalizationcostsforinpatientswithcopdaninterruptedtimeseriesstudy